COMMONWEALTH EQUITY SERVICES, LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 11 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$8,000
-20.0%
11,0000.0%0.00%
Q2 2022$10,0000.0%11,0000.0%0.00%
Q1 2022$10,0000.0%11,0000.0%0.00%
Q4 2021$10,0000.0%11,0000.0%0.00%
Q3 2021$10,0000.0%11,0000.0%0.00%
Q2 2021$10,0000.0%11,0000.0%0.00%
Q1 2021$10,0000.0%11,0000.0%0.00%
Q4 2020$10,0000.0%11,0000.0%0.00%
Q3 2020$10,0000.0%11,0000.0%0.00%
Q2 2020$10,0000.0%11,0000.0%0.00%
Q1 2020$10,0000.0%11,0000.0%0.00%
Q4 2019$10,000
+11.1%
11,0000.0%0.00%
Q3 2019$9,000
-10.0%
11,0000.0%0.00%
Q2 2019$10,0000.0%11,0000.0%0.00%
Q1 2019$10,000
+11.1%
11,0000.0%0.00%
Q4 2018$9,000
-10.0%
11,0000.0%0.00%
Q3 2018$10,000
-37.5%
11,000
-35.3%
0.00%
Q2 2018$16,000
+14.3%
17,0000.0%0.00%
Q1 2018$14,000
-6.7%
17,0000.0%0.00%
Q4 2017$15,00017,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q3 2021
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 83,413,000$130,650,0006.13%
AEGON USA Investment Management, LLC 6,000,000$9,368,0002.35%
MACKAY SHIELDS LLC 24,370,000$38,152,0002.07%
INCOME RESEARCH & MANAGEMENT 4,374,000$6,829,0001.11%
KINGDON CAPITAL MANAGEMENT, L.L.C. 20,000$20,347,0000.99%
SHENKMAN CAPITAL MANAGEMENT INC 5,269,000$8,264,0000.82%
Mitsubishi UFJ Securities Holdings Co., Ltd. 325,000$511,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 9,299,000$14,598,0000.47%
ADVENT CAPITAL MANAGEMENT /DE/ 14,543,000$23,021,0000.35%
CSS LLC/IL 3,750,000$5,893,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders